CD14 signaling reciprocally controls collagen deposition and turnover to regulate the development of lyme arthritis

American Journal of Pathology

Volumn 178, Issue 2, 2011, Pages 724-734

  Sahay, Bikash ^a   Singh, Anju ^a   Gnanamani, Arumugam ^b   Patsey, Rebeca L ^a   Blalock, J Edwin ^c   Sellati, Timothy J ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b CENTRAL LEATHER RESEARCH INSTITUTE   (India)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; COLLAGEN; GELATINASE; GELATINASE B; GLYCINE; PROLINE; TRIPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; LEUKOCYTE MIGRATION; LYME DISEASE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 79951836794     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.10.025     Document Type: Article

References (55)

1. Steere AC, Glickstein L: Elucidation of Lyme arthritis. Nat Rev Immunol 2004, 4:143-152 (Pubitemid 38209208)
2. Duray PH, Steere AC: Clinical pathologic correlations of Lyme disease by stage. Ann N Y Acad Sci 1988, 539:65-79
3. Brown CR, Blaho VA, Loiacono CM: Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein- 1 production in joints and requires neutrophil recruitment via CXCR2. J Immunol 2003, 171:893-901 (Pubitemid 36871402)
4. Brown CR, Blaho VA, Loiacono CM: Treatment of mice with the neutrophil-depleting antibody RB6-8C5 results in early development of experimental Lyme arthritis via the recruitment of Gr-1- polymorphonuclear leukocyte-like cells. Infect Immun 2004, 72:4956-4965 (Pubitemid 39223378)
5. Montgomery RR, Booth CJ, Wang X, Blaho VA, Malawista SE, Brown CR: Recruitment of macrophages and polymorphonuclear leukocytes in Lyme carditis. Infect Immun 2007, 75:613-620 (Pubitemid 46203423)
6. Xu Q, Seemanapalli SV, Reif KE, Brown CR, Liang FT: Increasing the recruitment of neutrophils to the site of infection dramatically attenuates Borrelia burgdorferi infectivity. J Immunol 2007, 178:5109-5115 (Pubitemid 46595294)
7. Sellati TJ, Burns MJ, Ficazzola MA, Furie MB: Borrelia burgdorferi upregulates expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro. Infect Immun 1995, 63:4439-4447
8. Wooten RM, Modur VR, McIntyre TM, Weis JJ: Borrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor-kappa B and inflammatory activation in human endothelial cells. J Immunol 1996, 157:4584-4590 (Pubitemid 126449380)
9. Sellati TJ, Abrescia LD, Radolf JD, Furie MB: Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro. Infect Immun 1996, 64:3180-3187 (Pubitemid 26256163)
10. Burns MJ, Sellati TJ, Teng EI, Furie MB: Production of interleukin-8 (IL-8) by cultured endothelial cells in response to Borrelia burgdorferi occurs independently of secreted [corrected] IL-1 and tumor necrosis factor alpha and is required for subsequent transendothelial migration of neutrophils. Infect Immun 1997, 65:1217-1222
11. Gallo RL, Kim KJ, Bernfield M, Kozak CA, Zanetti M, Merluzzi L, Gennaro R: Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem 1997, 272:13088-13093 (Pubitemid 27216731)
12. Nathan C: Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006, 6:173-182
13. Belaaouaj A, McCarthy R, Baumann M, Gao Z, Ley TJ, Abraham SN, Shapiro SD: Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med 1998, 4:615-618 (Pubitemid 28237363)
14. Malik M, Bakshi CS, McCabe K, Catlett SV, Shah A, Singh R, Jackson PL, Gaggar A, Metzger DW, Melendez JA, Blalock JE, Sellati TJ: Matrix metalloproteinase 9 activity enhances host susceptibility to pulmonary infection with type A and B strains of Francisella tularensis. J Immunol 2007, 178:1013-1020 (Pubitemid 46095174)
15. Weathington NM, van Houwelingen AH, Noerager BD, Jackson PL, Kraneveld AD, Galin FS, Folkerts G, Nijkamp FP, Blalock JE: A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med 2006, 12:317-323 (Pubitemid 43355080)
16. Gaggar A, Li Y, Weathington N, Winkler M, Kong M, Jackson P, Blalock JE, Clancy JP: Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. Am J Physiol Lung Cell Mol Physiol 2007, 293:L96-L104 (Pubitemid 47080717)
17. Gaggar A, Jackson PL, Noerager BD, O'Reilly PJ, McQuaid DB, Rowe SM, Clancy JP, Blalock JE: A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J Immunol 2008, 180:5662-5669
18. Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003, 92:827-839 (Pubitemid 36542523)
19. Wang F-q, So J, Reierstad S, Fishman DA: Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase. Int J Cancer 2005, 114:19-31 (Pubitemid 40194305)
20. Gong Y, Hart E, Shchurin A, Hoover-Plow J: Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Invest 2008, 118:3012-3024
21. Hu LT, Eskildsen MA, Masgala C, Steere AC, Arner EC, Pratta MA, Grodzinsky AJ, Loening A, Perides G: Host metalloproteinases in Lyme arthritis. Arthritis Rheum 2001, 44:1401-1410 (Pubitemid 32537540)
22. Kirchner A, Koedel U, Fingerle V, Paul R, Wilske B, Pfister HW: Upregulation of matrix metalloproteinase-9 in the cerebrospinal fluid of patients with acute Lyme neuroborreliosis. J Neurol Neurosurg Psychiatry 2000, 68:368-371 (Pubitemid 30248715)
23. Lin B, Kidder JM, Noring R, Steere AC, Klempner MS, Hu LT: Differences in synovial fluid levels of matrix metalloproteinases suggest separate mechanisms of pathogenesis in Lyme arthritis before and after antibiotic treatment. J Infect Dis 2001, 184:174-180 (Pubitemid 32614046)
24. Zhao Z, Chang H, Trevino RP, Whren K, Bhawan J, Klempner MS: Selective up-regulation of matrix metalloproteinase-9 expression in human erythema migrans skin lesions of acute Lyme disease. J Infect Dis 2003, 188:1098-1104 (Pubitemid 37338972)
25. Blalock JE: The immune system as the sixth sense. J Intern Med 2005, 257:126-138
26. Hubner A, Yang X, Nolen DM, Popova TG, Cabello FC, Norgard MV: Expression of Borrelia burgdorferi OspC and DbpA is controlled by a RpoN-RpoS regulatory pathway. Proc Natl Acad Sci U S A 2001, 98:12724-12729 (Pubitemid 33020013)
27. Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, Stewart CL, Goyert SM: Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996, 4:407-414 (Pubitemid 26174055)
28. Hibbs MS, Hasty KA, Seyer JM, Kang AH, Mainardi CL: Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 1985, 260:2493-2500 (Pubitemid 15104858)
29. Behera AK, Hildebrand E, Scagliotti J, Steere AC, Hu LT: Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine Lyme arthritis. Infect Immun 2005, 73:126-134 (Pubitemid 40041102)
30. Guo X, Booth CJ, Paley MA, Wang X, DePonte K, Fikrig E, Narasimhan S, Montgomery RR: Inhibition of neutrophil function by two tick salivary proteins. Infect Immun 2009, 77:2320-2329
31. Montgomery RR, Lusitani D, de Boisfleury CA, Malawista SE: Tick saliva reduces adherence and area of human neutrophils. Infect Immun 2004, 72:2989-2994 (Pubitemid 38542429)
32. Chang C, Houck JC: Demonstration of the chemotactic properties of collagen. Proc Soc Exp Biol Med 1970, 134:22-26
33. Pfister RR, Haddox JL, Lam KW, Lank KM: Preliminary characterization of a polymorphonuclear leukocyte stimulant isolated from alkali-treated collagen. Invest Ophthalmol Vis Sci 1988, 29:955-962
34. Pfister RR, Haddox JL, Sommers CI: Alkali-degraded cornea generates a low molecular weight chemoattractant for polymorphonuclear leukocytes. Invest Ophthalmol Vis Sci 1993, 34:2297-2304 (Pubitemid 23191258)
35. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs- Mecarelli L: Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000, 80:617-653
36. Cascão R, Rosário HS, Souto-Carneiro MM, Fonseca JE: Neutrophils in rheumatoid arthritis: more than simple final effectors. Autoimmun Rev 2010, 9:531-535
37. Burrage PS, Mix KS, Brinckerhoff CE: Matrix metalloproteinases: role in arthritis. Front Biosci 2006, 11:529-543 (Pubitemid 43258162)
38. Chang YH, Lin IL, Tsay GJ, Yang SC, Yang TP, Ho KT, Hsu TC, Shiau MY: Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Biochem 2008, 41:955-959
39. Sjostedt A, Conlan JW, North RJ: Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection. Infect Immun 1994, 62:2779-2783 (Pubitemid 24203960)
40. Renckens R, Roelofs JJTH, Florquin S, de Vos AF, Lijnen HR, van'T Veer C, van der Poll T: Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis. J Immunol 2006, 176:3735-3741 (Pubitemid 43364020)
41. Calander A-M, Starckx S, Opdenakker G, Bergin P, Quiding-Järbrink M, Tarkowski A: Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis. Microb Infect 2006, 8:1434-1439 (Pubitemid 43903311)
42. Heilpern AJ, Wertheim W, He J, Perides G, Bronson RT, Hu LT: Matrix metalloproteinase 9 plays a key role in Lyme arthritis but not in dissemination of Borrelia burgdorferi. Infect Immun 2009, 77:2643-2649
43. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat M-L, Gabbiani G: The myofibroblast: one function, multiple origins. Am J Pathol 2007, 170:1807-1816 (Pubitemid 47339255)
44. Kuwana M, Okazaki Y, Kodama H, Izumi K, Yasuoka H, Ogawa Y, Kawakami Y, Ikeda Y: Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol 2003, 74:833-845 (Pubitemid 38040360)
45. Greene CM, Branagan P, McElvaney NG: Toll-like receptors as therapeutic targets in cystic fibrosis. Exp Opin Ther Targets 2008, 12:1481-1495
46. Muir A, Soong G, Sokol S, Reddy B, Gomez MI, van Heeckeren A, Prince A: Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol 2004, 30:777-783 (Pubitemid 38736900)
47. Shuto T, Furuta T, Oba M, Xu H, Li JD, Cheung J, Gruenert DC, Uehara A, Suico MA, Okiyoneda T, Kai H: Promoter hypomethylation of Toll-like receptor-2 gene is associated with increased proinflammatory response toward bacterial peptidoglycan in cystic fibrosis bronchial epithelial cells. FASEB J 2006, 20:782-784 (Pubitemid 46671214)
48. Leemans JC, Butter LM, Pulskens WPC, Teske GJD, Claessen N, van der Poll T, Florquin S: The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS One 2009, 4:e5704
49. Niu X-L, Yang X, Hoshiai K, Tanaka K, Sawamura S, Koga Y, Nakazawa H: Inducible nitric oxide synthase deficiency does not affect the susceptibility of mice to atherosclerosis but increases collagen content in lesions. Circulation 2001, 103:1115-1120 (Pubitemid 32200186)
50. Liang FT, Brown EL, Wang T, Iozzo RV, Fikrig E: Protective niche for Borrelia burgdorferi to evade humoral immunity. Am J Pathol 2004, 165:977-985 (Pubitemid 39129304)
51. Xu Q, Seemanaplli SV, McShan K, Liang FT: Increasing the interaction of Borrelia burgdorferi with decorin significantly reduces the 50 percent infectious dose and severely impairs dissemination. Infect Immun 2007, 75:4272-4281 (Pubitemid 47378083)
52. Priem S, Burmester GR, Kamradt T, Wolbart K, Rittig MG, Krause A: Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy. Ann Rheum Dis 1998, 57:118-121 (Pubitemid 28177543)
53. Hodzic E, Feng S, Holden K, Freet KJ, Barthold SW: Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob Agents Chemother 2008, 52:1728-1736 (Pubitemid 351614666)
54. Haupl T, Hahn G, Rittig M, Krause A, Schoerner C, Schonherr U, Kalden JR, Burmester GR: Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis. Arthritis Rheum 1993, 36:1621-1626 (Pubitemid 23327762)
55. Barthold SW, Hodzic E, Tunev S, Feng S: Antibody-mediated disease remission in the mouse model of Lyme borreliosis. Infect Immun 2006, 74:4817-4825 (Pubitemid 44157269)